| Anthem Biosciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544449 |
NSE Symbol : ANTHEM |
P/E(TTM) : 62.35 |
|
ISIN Demat : INE0CZ201020 |
Div & Yield% : 0.00 |
EPS(TTM) : 12.22 |
|
Book Value(₹) : 56.55 |
Market Cap(₹Cr) : 42,912.65 |
Face Value(₹) : 2.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 582.50 | 416.58 | 552.23 | 538.01 | 478.98 | 498.26 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 582.50 | 416.58 | 552.23 | 538.01 | 478.98 | 498.26 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 61.60 | 39.92 | 53.80 | 27.73 | 37.82 | 24.34 |
| Total Income | 644.10 | 456.50 | 606.03 | 565.74 | 516.80 | 522.60 |
| Total Expenditure | 315.51 | 278.51 | 326.57 | 342.58 | 280.87 | 331.41 |
| PBIDT | 328.59 | 177.98 | 279.45 | 223.16 | 235.93 | 191.19 |
| Interest | 1.58 | 1.13 | 2.23 | 1.61 | 2.10 | 1.79 |
| PBDT | 327.01 | 176.86 | 277.22 | 221.55 | 233.83 | 189.41 |
| Depreciation | 26.28 | 26.75 | 23.92 | 22.61 | 20.99 | 19.50 |
| Tax | 89.71 | 37.78 | 63.75 | 50.07 | 56.54 | 42.76 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.65 | 0.21 | -8.88 | 0.53 | 33.73 | -0.85 |
| Reported Profit After Tax | 211.67 | 112.12 | 198.43 | 148.34 | 122.56 | 127.99 |
| Extra-ordinary Items | 0.68 | -18.66 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 210.99 | 130.78 | 198.43 | 148.34 | 122.56 | 127.99 |
| EPS (Unit Curr.) | 3.77 | 2.00 | 3.54 | 2.65 | 2.19 | 2.29 |
| EPS (Adj) (Unit Curr.) | 3.77 | 2.00 | 3.54 | 2.65 | 2.19 | 2.29 |
| Calculated EPS (Unit Curr.) | 3.77 | 2.00 | 3.53 | 2.65 | 2.19 | 2.29 |
| Calculated EPS (Adj) (Unit Curr.) | 3.77 | 2.00 | 3.53 | 2.65 | 2.19 | 2.29 |
| Calculated EPS (Ann.) (Unit Curr.) | 15.07 | 7.99 | 14.13 | 10.61 | 8.77 | 9.16 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 15.07 | 7.99 | 14.13 | 10.61 | 8.77 | 9.16 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 112.34 | 112.32 | 112.32 | 111.82 | 111.82 | 111.82 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 56.41 | 42.72 | 50.60 | 41.48 | 49.26 | 38.37 |
| PBDTM(%) | 56.14 | 42.46 | 50.20 | 41.18 | 48.82 | 38.01 |
| PATM(%) | 36.34 | 26.91 | 35.93 | 27.57 | 25.59 | 25.69 |
